ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Penumbra, Inc. (PEN)

NYSE · Common stock · Surgical & Medical Instruments & Apparatus

$324.08-0.26 (-0.08%)

As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow PEN in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on PEN and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free PEN chart →

PEN at a glance

Key statistics

$12.78B

Market capitalization

Previous close
$324.34
Open
$324.69
Day range
$321.97 – $324.77
Volume
238.1K
Average volume (30 sessions)
369.2K
Shares outstanding
39.39M
Price / earnings
79.5
Earnings per share
$4.08
Price / book
8.3
Price / sales
8.5
Beta (1 year, vs SPY)
0.03

Where the price sits in its year

52-week range

73% of the range

Below the 52-week high
-10.6%
Above the 52-week low
+46.5%

Completed sessions through Oct 20, 2026

Technical snapshot

Above its 50-day average, below its 200-day

20-day average
$319.37+1.6%
50-day average
$321.06+1.0%
200-day average
$327.18-0.9%
RSI (14)67.7

Between the conventional 30 and 70 bands.

+1.4%

1 week

+1.7%

1 month

+2.5%

3 months

+4.3%

Year to date

+30.3%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with PEN

Every plan

PEN on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on PEN.

See the plans →

Every plan

Screen names like PEN

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on PEN

Put PEN on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on PEN

See whether there is an open premium alert on PEN, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

PEN headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Narayan Shruthi

    −1.4K

    President · Shares withheld for tax

    $439.08K · Oct 15, 2026

  • Narayan Shruthi

    −1.2K

    President · Shares withheld for tax

    $391.67K · Sep 15, 2026

  • Narayan Shruthi

    +3.1K

    President · Grant or award

    · Aug 17, 2026

  • Elsesser Adam

    −77.0K

    CEO, Director · Gift

    · May 19, 2026

  • Grewal Harpreet

    −100

    Director · Open-market sale

    $32.82K · Apr 2, 2026

  • Narayan Shruthi

    −117

    President · Shares withheld for tax

    $39.33K · Mar 15, 2026

  • Shiu Lambert

    −150

    Chief Accounting Officer · Shares withheld for tax

    $50.43K · Mar 15, 2026

  • Roberts Johanna

    −186

    EVP, Gen. Counsel & Secretary · Shares withheld for tax

    $62.53K · Mar 15, 2026

About Penumbra, Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Exchange
NYSE
Security
Common stock
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Alameda, CA
Employees
4,700
Listed since
Sep 18, 2015
Website
penumbrainc.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.